Manufacturer record
Themis Medicare Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Themis Medicare Limited (Uttarakhand) were declared Not of Standard Quality between December 2021 and April 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Themis Medicare Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Bupivacaine Hydrochloride Injection IP (Bupicain-0.5%) | BPC24007Mfg 2024-12 · Exp 2026-10 | Particulate matter and DescriptionDescription | CDL KolkataCDSCO lab | Apr 2025 |
| Bupicain- Heavy 4 ml (Bupivacaine Hydrochloride with Dextrose Injection U.S.P.) | BUI22003Mfg 2022-04 · Exp 2024-03 | Assay of DextroseAssay | CDL KolkataCDSCO lab | Nov 2022 |
| Themidon (Trimetazidine Dihydrochloride Tablets IP) | TDN003Mfg 2020-07 · Exp 2023-06 | AssayAssay | CDTL MumbaiCDSCO lab | Dec 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.